Alan F. Denenberg
Lawyers
Filters
NVIDIA $5 billion notes offering
Davis Polk advised the sole underwriter in connection with a $5.0 billion SEC-registered notes offering by NVIDIA Corporation, consisting of $1.5 billion aggregate principal amount of…
Weyerhaeuser $750 million bond offering
Davis Polk advised the joint book-running managers, in connection with an SEC-registered offering by Weyerhaeuser Company of $750 million aggregate principal amount of its 4.00% senior…
NIKE $6 billion notes offering
Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with a $6.0 billion SEC-registered notes offering by NIKE, Inc., consisting of …
Intel $8 billion senior notes offering
Davis Polk advised the joint book-running managers in connection with an $8.0 billion SEC-registered debt offering by Intel Corporation. The offering consisted of $1.5 billion…
Microchip Technology $615 million convertible notes exchanges
Davis Polk is advising the financial adviser to Microchip Technology Incorporated in connection with Microchip’s privately negotiated exchanges of $615 million aggregate principal amount of…
McKesson splits off interest in Change Healthcare
Davis Polk advised McKesson Corporation in connection with the offer by McKesson to exchange shares of McKesson common stock for shares of PF2 SpinCo, Inc. (“SpinCo”) common stock owned by…
NanoString Technologies $230 million convertible senior notes offering
Davis Polk advised the initial purchasers in connection with a Rule 144A offering by NanoString Technologies, Inc. of $230 million aggregate principal amount of its 2.625% convertible…
NuVasive $450 million convertible senior notes offering
Davis Polk advised the initial purchasers in connection with a Rule 144A offering by NuVasive, Inc. of $450 million aggregate principal amount of its 0.375% convertible senior notes due…
CytomX Therapeutics $75 million at-the-market offering
Davis Polk advised the sales agent in connection with the SEC-registered at-the-market offering by CytomX Therapeutics, Inc. of its common stock for up to an aggregate amount of $75 million…
Citrix $750 million notes offering
Davis Polk advised the underwriters in connection with an SEC-registered offering by Citrix Systems, Inc. of $750 million aggregate principal amount of its 3.300% senior notes due 2030…